Skip to main content
Erschienen in: European Journal of Nutrition 3/2019

21.02.2018 | Original Contribution

Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer

verfasst von: Nuri El-azem, Mario Pulido-Moran, Cesar L. Ramirez-Tortosa, Jose L. Quiles, Francisca E. Cara, Pedro Sanchez-Rovira, Sergio Granados-Principal, MCarmen Ramirez-Tortosa

Erschienen in: European Journal of Nutrition | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The main objective of this study was to test the therapeutic potential of hydroxytyrosol and its combination with paclitaxel in breast cancer on oxidative stress status.

Methods

Impact on proliferation rates of different chemotherapy administration patterns was assayed in MCF-7 and MDA-MB-231 breast cancer cell lines. Breast tumor-bearing rats were randomly assigned to Control, Hydroxytyrosol, Paclitaxel and Paclitaxel plus hydroxytyrosol groups, for 6 weeks. Tumor volume, cell proliferation and several systemic oxidative stress parameters were measured. Anti-proliferative activity in vitro experiments was correlated with in vivo experiments.

Results

Combination group did significantly reduce tumor volume when compared with paclitaxel alone. Additionally, the combination improved the antioxidant status without compromising the antitumor activity of standard chemotherapy.

Conclusion

These findings reveal for the first time that hydroxytyrosol is an active partner in combined therapies with paclitaxel against breast cancer. Combination with hydroxytyrosol would also ensure a less oxidative impact of chemotherapeutic drugs that could potentially improve patient wellness.
Literatur
1.
Zurück zum Zitat Gomez SL, Von Behren J, McKinley M, Clarke CA, Shariff-Marco S, Cheng I, Reynolds P, Glaser SL (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164(1):139–147PubMedPubMedCentralCrossRef Gomez SL, Von Behren J, McKinley M, Clarke CA, Shariff-Marco S, Cheng I, Reynolds P, Glaser SL (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164(1):139–147PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. J Natl Cancer Inst 109(9). https://doi.org/10.1093/jnci/djx030 Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. J Natl Cancer Inst 109(9). https://​doi.​org/​10.​1093/​jnci/​djx030
3.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef
4.
Zurück zum Zitat Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa CL, Quiles JL, Ramirez-Tortosa M, Lorente JA (2013) Transcriptional shift identifies a set of genes driving breast cancer chemoresistance. PLoS One 8(1):e53983PubMedPubMedCentralCrossRef Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa CL, Quiles JL, Ramirez-Tortosa M, Lorente JA (2013) Transcriptional shift identifies a set of genes driving breast cancer chemoresistance. PLoS One 8(1):e53983PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Wu X, Ye Y, Barcenas CH, Chow W-H, Meng QH, Chavez-MacGregor M, Hildebrandt MAT, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN (2017) Personalized prognostic prediction models for breast cancer recurrence and survival incorporating multidimensional data. J Natl Cancer Inst 109(7). https://doi.org/10.1093/jnci/djw314 Wu X, Ye Y, Barcenas CH, Chow W-H, Meng QH, Chavez-MacGregor M, Hildebrandt MAT, Zhao H, Gu X, Deng Y, Wagar E, Esteva FJ, Tripathy D, Hortobagyi GN (2017) Personalized prognostic prediction models for breast cancer recurrence and survival incorporating multidimensional data. J Natl Cancer Inst 109(7). https://​doi.​org/​10.​1093/​jnci/​djw314
6.
Zurück zum Zitat Buckland G, Gonzalez CA (2015) The role of olive oil in disease prevention: a focus on the recent epidemiological evidence from cohort studies and dietary intervention trials. Br J Nutr 113(Suppl 2):S94-101PubMed Buckland G, Gonzalez CA (2015) The role of olive oil in disease prevention: a focus on the recent epidemiological evidence from cohort studies and dietary intervention trials. Br J Nutr 113(Suppl 2):S94-101PubMed
7.
Zurück zum Zitat Rodriguez-Morato J, Xicota L, Fito M, Farre M, Dierssen M, de la Torre R (2015) Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases. Molecules 20(3):4655–4680PubMedPubMedCentralCrossRef Rodriguez-Morato J, Xicota L, Fito M, Farre M, Dierssen M, de la Torre R (2015) Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases. Molecules 20(3):4655–4680PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Ochoa-Herrera J, Perez-Lopez P, Pulido-Moran M, Ramirez-Tortosa MC (2012) Squalene ameliorates atherosclerotic lesions through the reduction of CD36 scavenger receptor expression in macrophages. Mol Nutr Food Res 56(5):733–740PubMedCrossRef Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Ochoa-Herrera J, Perez-Lopez P, Pulido-Moran M, Ramirez-Tortosa MC (2012) Squalene ameliorates atherosclerotic lesions through the reduction of CD36 scavenger receptor expression in macrophages. Mol Nutr Food Res 56(5):733–740PubMedCrossRef
9.
Zurück zum Zitat Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC (2010) Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68(4):191–206PubMedCrossRef Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC (2010) Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68(4):191–206PubMedCrossRef
11.
Zurück zum Zitat Catalan U, Rubio L, Lopez de Las Hazas M-C, Herrero P, Nadal P, Canela N, Pedret A, Motilva M-J, Sola R (2016) Hydroxytyrosol and its complex forms (secoiridoids) modulate aorta and heart proteome in healthy rats: Potential cardio-protective effects. Mol Nutr Food Res 60(10):2114–2129PubMedCrossRef Catalan U, Rubio L, Lopez de Las Hazas M-C, Herrero P, Nadal P, Canela N, Pedret A, Motilva M-J, Sola R (2016) Hydroxytyrosol and its complex forms (secoiridoids) modulate aorta and heart proteome in healthy rats: Potential cardio-protective effects. Mol Nutr Food Res 60(10):2114–2129PubMedCrossRef
12.
Zurück zum Zitat Medina-Martinez MS, Truchado P, Castro-Ibanez I, Allende A (2016) Antimicrobial activity of hydroxytyrosol: a current controversy. Biosci Biotechnol Biochem 80(4):801–810PubMedCrossRef Medina-Martinez MS, Truchado P, Castro-Ibanez I, Allende A (2016) Antimicrobial activity of hydroxytyrosol: a current controversy. Biosci Biotechnol Biochem 80(4):801–810PubMedCrossRef
13.
Zurück zum Zitat Warleta F, Quesada CS, Campos M, Allouche Y, Beltran G, Gaforio JJ (2011) Hydroxytyrosol protects against oxidative DNA damage in human breast cells. Nutrients 3(10):839–857PubMedPubMedCentralCrossRef Warleta F, Quesada CS, Campos M, Allouche Y, Beltran G, Gaforio JJ (2011) Hydroxytyrosol protects against oxidative DNA damage in human breast cells. Nutrients 3(10):839–857PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Zheng A, Li H, Cao K, Xu J, Zou X, Li Y, Chen C, Liu J, Feng Z (2015) Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspring. J Nutr Biochem 26(2):190–199PubMedCrossRef Zheng A, Li H, Cao K, Xu J, Zou X, Li Y, Chen C, Liu J, Feng Z (2015) Maternal hydroxytyrosol administration improves neurogenesis and cognitive function in prenatally stressed offspring. J Nutr Biochem 26(2):190–199PubMedCrossRef
15.
Zurück zum Zitat Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, Tonic I, Unterman T, Hay N (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14(6):458–470PubMedPubMedCentralCrossRef Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, Tonic I, Unterman T, Hay N (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14(6):458–470PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Notarnicola M, Pisanti S, Tutino V, Bocale D, Rotelli MT, Gentile A, Memeo V, Bifulco M, Perri E, Caruso MG (2011) Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr 6(1):63–69PubMedCrossRef Notarnicola M, Pisanti S, Tutino V, Bocale D, Rotelli MT, Gentile A, Memeo V, Bifulco M, Perri E, Caruso MG (2011) Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr 6(1):63–69PubMedCrossRef
17.
Zurück zum Zitat Granados-Principal S, Quiles JL, Ramirez-Tortosa C, Camacho-Corencia P, Sanchez-Rovira P, Vera-Ramirez L, Ramirez-Tortosa MC (2011) Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol Nutr Food Res 55(Suppl 1):S117–S126 Granados-Principal S, Quiles JL, Ramirez-Tortosa C, Camacho-Corencia P, Sanchez-Rovira P, Vera-Ramirez L, Ramirez-Tortosa MC (2011) Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol Nutr Food Res 55(Suppl 1):S117–S126
18.
Zurück zum Zitat Jezierska-Drutel A, Rosenzweig SA, Neumann CA (2013) Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119:107–125PubMedPubMedCentralCrossRef Jezierska-Drutel A, Rosenzweig SA, Neumann CA (2013) Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119:107–125PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Castel M, Despas F, Modesto A, Gales C, Honton B, Galinier M, Senard J-M, Pathak A (2013) [Cardiotoxicity of chemotherapies]. Effets indesirables cardiaques des chimiotherapies. Presse Med 42(1):26–39PubMedCrossRef Castel M, Despas F, Modesto A, Gales C, Honton B, Galinier M, Senard J-M, Pathak A (2013) [Cardiotoxicity of chemotherapies]. Effets indesirables cardiaques des chimiotherapies. Presse Med 42(1):26–39PubMedCrossRef
20.
Zurück zum Zitat Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC (2010) New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 48(6):1425–1438PubMedCrossRef Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC (2010) New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 48(6):1425–1438PubMedCrossRef
21.
Zurück zum Zitat Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Fernandez-Navarro M, Lorente JA, Quiles JL (2011) Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients? Antioxid Redox Signal 15(4):903–909PubMedCrossRef Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Fernandez-Navarro M, Lorente JA, Quiles JL (2011) Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients? Antioxid Redox Signal 15(4):903–909PubMedCrossRef
22.
Zurück zum Zitat Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, Quiles JL (2012) Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates. Free Radic Res 46(1):2–10PubMedCrossRef Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JA, Quiles JL (2012) Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates. Free Radic Res 46(1):2–10PubMedCrossRef
23.
Zurück zum Zitat Varela-Lopez A, Ochoa JJ, Llamas-Elvira JM, Lopez-Frias M, Planells E, Ramirez-Tortosa M, Ramirez-Tortosa CL, Giampieri F, Battino M, Quiles JL (2017) Age-related loss in bone mineral density of rats fed lifelong on a fish oil-based diet is avoided by coenzyme Q10 addition. Nutrients 9(2):pii: E176. https://doi.org/10.3390/nu9020176 CrossRef Varela-Lopez A, Ochoa JJ, Llamas-Elvira JM, Lopez-Frias M, Planells E, Ramirez-Tortosa M, Ramirez-Tortosa CL, Giampieri F, Battino M, Quiles JL (2017) Age-related loss in bone mineral density of rats fed lifelong on a fish oil-based diet is avoided by coenzyme Q10 addition. Nutrients 9(2):pii: E176. https://​doi.​org/​10.​3390/​nu9020176 CrossRef
24.
Zurück zum Zitat Vera-Ramirez L, Ramirez-Tortosa M, Perez-Lopez P, Granados-Principal S, Battino M, Quiles JL (2012) Long-term effects of systemic cancer treatment on DNA oxidative damage: the potential for targeted therapies. Cancer Lett 327(1–2):134–141PubMedCrossRef Vera-Ramirez L, Ramirez-Tortosa M, Perez-Lopez P, Granados-Principal S, Battino M, Quiles JL (2012) Long-term effects of systemic cancer treatment on DNA oxidative damage: the potential for targeted therapies. Cancer Lett 327(1–2):134–141PubMedCrossRef
25.
Zurück zum Zitat McCormick B, Lowes DA, Colvin L, Torsney C, Galley HF (2016) MitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mitochondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain model. Br J Anaesth 117(5):659–666PubMedCrossRef McCormick B, Lowes DA, Colvin L, Torsney C, Galley HF (2016) MitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mitochondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain model. Br J Anaesth 117(5):659–666PubMedCrossRef
26.
Zurück zum Zitat Sarsour EH, Goswami M, Kalen AL, Lafin JT, Goswami PC (2014) Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation. Age (Dordr) 36(3):9645CrossRef Sarsour EH, Goswami M, Kalen AL, Lafin JT, Goswami PC (2014) Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation. Age (Dordr) 36(3):9645CrossRef
27.
Zurück zum Zitat Toteda G, Lupinacci S, Vizza D, Bonofiglio R, Perri E, Bonofiglio M, Lofaro D, La Russa A, Leone F, Gigliotti P, Cifarelli RA, Perri A (2017) High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells. J Endocrinol Invest 40(2):153–162PubMedCrossRef Toteda G, Lupinacci S, Vizza D, Bonofiglio R, Perri E, Bonofiglio M, Lofaro D, La Russa A, Leone F, Gigliotti P, Cifarelli RA, Perri A (2017) High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells. J Endocrinol Invest 40(2):153–162PubMedCrossRef
28.
Zurück zum Zitat Granados-Principal S, El-Azem N, Pamplona R, Ramirez-Tortosa C, Pulido-Moran M, Vera-Ramirez L, Quiles JL, Sanchez-Rovira P, Naudi A, Portero-Otin M, Perez-Lopez P, Ramirez-Tortosa M (2014) Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer. Biochem Pharmacol 90(1):25–33PubMedCrossRef Granados-Principal S, El-Azem N, Pamplona R, Ramirez-Tortosa C, Pulido-Moran M, Vera-Ramirez L, Quiles JL, Sanchez-Rovira P, Naudi A, Portero-Otin M, Perez-Lopez P, Ramirez-Tortosa M (2014) Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer. Biochem Pharmacol 90(1):25–33PubMedCrossRef
29.
Zurück zum Zitat Rosignoli P, Fuccelli R, Sepporta MV, Fabiani R (2016) In vitro chemo-preventive activities of hydroxytyrosol: the main phenolic compound present in extra-virgin olive oil. Food Funct 7(1):301–307PubMedCrossRef Rosignoli P, Fuccelli R, Sepporta MV, Fabiani R (2016) In vitro chemo-preventive activities of hydroxytyrosol: the main phenolic compound present in extra-virgin olive oil. Food Funct 7(1):301–307PubMedCrossRef
30.
Zurück zum Zitat Cardeno A, Sanchez-Hidalgo M, Rosillo MA, Alarcon de la Lastra C (2013) Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1alpha. Nutr Cancer 65(1):147–156PubMedCrossRef Cardeno A, Sanchez-Hidalgo M, Rosillo MA, Alarcon de la Lastra C (2013) Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1alpha. Nutr Cancer 65(1):147–156PubMedCrossRef
31.
Zurück zum Zitat Sirianni R, Chimento A, De Luca A, Casaburi I, Rizza P, Onofrio A, Iacopetta D, Puoci F, Ando S, Maggiolini M, Pezzi V (2010) Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res 54(6):833–840PubMedCrossRef Sirianni R, Chimento A, De Luca A, Casaburi I, Rizza P, Onofrio A, Iacopetta D, Puoci F, Ando S, Maggiolini M, Pezzi V (2010) Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res 54(6):833–840PubMedCrossRef
32.
Zurück zum Zitat Alvarado A, Lopes AC, Faustino-Rocha AI, Cabrita AMS, Ferreira R, Oliveira PA, Colaco B (2017) Prognostic factors in MNU and DMBA-induced mammary tumors in female rats. Pathol Res Pract 213(5):441–446PubMedCrossRef Alvarado A, Lopes AC, Faustino-Rocha AI, Cabrita AMS, Ferreira R, Oliveira PA, Colaco B (2017) Prognostic factors in MNU and DMBA-induced mammary tumors in female rats. Pathol Res Pract 213(5):441–446PubMedCrossRef
33.
Zurück zum Zitat Terzuoli E, Nannelli G, Frosini M, Giachetti A, Ziche M, Donnini S (2017) Inhibition of cell cycle progression by the hydroxytyrosol–cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells. Oncotarget 8(47):83207–88322PubMedPubMedCentralCrossRef Terzuoli E, Nannelli G, Frosini M, Giachetti A, Ziche M, Donnini S (2017) Inhibition of cell cycle progression by the hydroxytyrosol–cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells. Oncotarget 8(47):83207–88322PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Burcombe R, Wilson G, Dowsett M, Khan I, Richman P, Daley F, Detre S, Makris A (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res 8:R31PubMedPubMedCentralCrossRef Burcombe R, Wilson G, Dowsett M, Khan I, Richman P, Daley F, Detre S, Makris A (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res 8:R31PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Tokuda E, Horimoto Y, Arakawa A, Himuro T, Senuma K, Nakai K, Saito M (2017) Differences in Ki67 expressions between pre-and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer. Hum Pathol 63:40–45PubMedCrossRef Tokuda E, Horimoto Y, Arakawa A, Himuro T, Senuma K, Nakai K, Saito M (2017) Differences in Ki67 expressions between pre-and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer. Hum Pathol 63:40–45PubMedCrossRef
36.
Zurück zum Zitat Enomoto Y, Morimoto T, Nishimukai A, Higuchi T, Yanai A, Miyagawa Y, Murase K, Imamura M, Takatsuka Y, Nomura T, Takeda M, Watanabe T, Hirota S, Miyoshi Y (2016) Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers. Int J Clin Oncol 21:254–261PubMedCrossRef Enomoto Y, Morimoto T, Nishimukai A, Higuchi T, Yanai A, Miyagawa Y, Murase K, Imamura M, Takatsuka Y, Nomura T, Takeda M, Watanabe T, Hirota S, Miyoshi Y (2016) Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers. Int J Clin Oncol 21:254–261PubMedCrossRef
37.
Zurück zum Zitat Diaz-Botero S, Espinosa-Bravo M, Gonçalves VR, Esgueva-Colmenarejo A, Peg V, Perez J, Cortes J (2016) Rubio IT. Different prognostic implications of residual disease after neoadjuvant treatment: impact of Ki 67 and site of response. Ann Surg Oncol 23:3831–3837PubMedCrossRef Diaz-Botero S, Espinosa-Bravo M, Gonçalves VR, Esgueva-Colmenarejo A, Peg V, Perez J, Cortes J (2016) Rubio IT. Different prognostic implications of residual disease after neoadjuvant treatment: impact of Ki 67 and site of response. Ann Surg Oncol 23:3831–3837PubMedCrossRef
40.
Zurück zum Zitat Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40(2):95–112PubMedPubMedCentralCrossRef Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40(2):95–112PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Panis C, Herrera ACSA., Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simao AN, Cecchini AL, Cecchini R (2012) Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133(1):89–97PubMedCrossRef Panis C, Herrera ACSA., Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simao AN, Cecchini AL, Cecchini R (2012) Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133(1):89–97PubMedCrossRef
42.
Zurück zum Zitat Barnett LE, Broomfield AM, Hendriks WH, Hunt MB, McGhie TK (2007) The in vivo antioxidant action and the reduction of oxidative stress by boysenberry extract is dependent on base diet constituents in rats. J Med Food 10(2):281–289PubMedCrossRef Barnett LE, Broomfield AM, Hendriks WH, Hunt MB, McGhie TK (2007) The in vivo antioxidant action and the reduction of oxidative stress by boysenberry extract is dependent on base diet constituents in rats. J Med Food 10(2):281–289PubMedCrossRef
43.
Zurück zum Zitat Fukui M, Yamabe N, Zhu BT (2010) Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 46(10):1882–1891PubMedPubMedCentralCrossRef Fukui M, Yamabe N, Zhu BT (2010) Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 46(10):1882–1891PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Marone M, D’Andrilli G, Das N, Ferlini C, Chatterjee S, Scambia G (2001) Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases. Exp Cell Res 270(1):1–12PubMedCrossRef Marone M, D’Andrilli G, Das N, Ferlini C, Chatterjee S, Scambia G (2001) Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases. Exp Cell Res 270(1):1–12PubMedCrossRef
45.
Zurück zum Zitat Robles-Almazan M, Pulido-Moran M, Moreno Fernandez J, Ramirez-Tortosa C, Rodriguez-Garcia C, Quiles JL, Ramirez-Tortosa MC (2018) Hydroxytyrosol: Bioavailability, toxicity and clinical applications. Food Res Int 2018(105):654–667CrossRef Robles-Almazan M, Pulido-Moran M, Moreno Fernandez J, Ramirez-Tortosa C, Rodriguez-Garcia C, Quiles JL, Ramirez-Tortosa MC (2018) Hydroxytyrosol: Bioavailability, toxicity and clinical applications. Food Res Int 2018(105):654–667CrossRef
Metadaten
Titel
Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer
verfasst von
Nuri El-azem
Mario Pulido-Moran
Cesar L. Ramirez-Tortosa
Jose L. Quiles
Francisca E. Cara
Pedro Sanchez-Rovira
Sergio Granados-Principal
MCarmen Ramirez-Tortosa
Publikationsdatum
21.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 3/2019
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1638-9

Weitere Artikel der Ausgabe 3/2019

European Journal of Nutrition 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.